Mostrar el registro sencillo del ítem

dc.creatorMartiñón, Susanaes_ES
dc.creatorCisneros, Angeles_ES
dc.creatorVillicaña, Sergioes_ES
dc.creatorHernández-Miramontes, Ricardoes_ES
dc.creatorMixcoha, Edgares_ES
dc.creatorCalderón-Vargas, Psychées_ES
dc.date2019
dc.date.accessioned2022-11-25T19:10:34Z
dc.date.available2022-11-25T19:10:34Z
dc.date.issued2019
dc.identifierMT02IC22
dc.identifier.issn2314-8861
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/7634
dc.identifier.urihttps://doi.org/10.1155/2019/3974127
dc.descriptionAdjuvants are a diverse family of substances whose main objective is to increase the strength, quality, and duration of the immune response caused by vaccines. The most commonly used adjuvants are aluminum-based, oil-water emulsion, and bacterial-origin adjuvants. In this paper, we will discuss how the election of adjuvants is important for the adjuvant-mediated induction of immunity for different types of vaccines. Aluminum-based adjuvants are the most commonly used, the safest, and have the best efficacy, due to the triggering of a strong humoral response, albeit generating a weak induction of cell-mediated immune response. Freund’s adjuvant is the most widely used oil-water emulsion adjuvant in animal trials; it stimulates inflammation and causes aggregation and precipitation of soluble protein antigens that facilitate the uptake by antigen-presenting cells (APCs). Adjuvants of bacterial origin, such as flagellin, E. coli membranes, and monophosphoryl lipid A (MLA), are known to potentiate immune responses, but their safety and risks are the main concern of their clinical use. This minireview summarizes the mechanisms that classic and novel adjuvants produce to stimulate immune responses.
dc.formatPDF
dc.language.isoeng
dc.publisherHindawi Publishing Corporation
dc.relation2019:3974127
dc.rightsAcceso Cerrado
dc.titleChemical and immunological characteristics of aluminum-based, oil-water emulsion, and bacterial-origin adjuvantses_ES
dc.typeArtículo
dc.contributor.affiliationNeuropharmacology, Biotechnology and Experimental Therapeutic Anti-Addictions Laboratory, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico
dc.contributor.emailsusimar2000@yahoo.com (Martiñón, Susana)
dc.relation.jnabreviadoJ IMMUNOL RES
dc.relation.journalJournal of Immunology Research
dc.identifier.placeEgipto
dc.date.published2019
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.eissn2314-7156
dc.identifier.doi10.1155/2019/3974127


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem